Parkinson’s disease is a motor system disorder that often appears in people over the age of 50. Early symptoms tend to be subtle and progress at different rates among patients. The condition is marked by the gradual loss of brain cells that produce dopamine, a neurotransmitter important for movement, memory, and cognition. As dopamine levels drop, individuals experience slower movements, balance problems, tremors, and other related symptoms.
At Capital Health’s Capital Institute for Neurosciences, Dr. Alexandre Mason Sharma provides new treatment options for those with Parkinson’s disease. He is a board certified specialist in movement disorders and has introduced subcutaneous levodopa pumps for patients with advanced stages of the disease.
Levodopa remains the standard medication used to manage Parkinson’s symptoms by supporting healthier dopamine levels. Dr. Mason Sharma explained: “Levodopa pills are often prescribed to patients in the earlier stages of Parkinson’s disease,” said Dr. Mason Sharma. “However, as the disease progresses, maintaining stable dopamine levels with pills can be a challenge. Wearable levodopa pumps (about the size of a smartphone) replace pills entirely, continuously injecting medication under the skin to maintain more consistent dopamine levels throughout the day. No surgery is required, and dosages are tailored to each patient’s needs so they can experience a better quality of life.”
Dr. Mason Sharma earned his medical degree from Boston University in Massachusetts and completed his neurology residency at Cooper University Hospital in Camden, New Jersey. He also finished fellowship training in movement disorders at Medstar Health/Georgetown University in Washington, D.C., and has contributed research published in peer-reviewed journals and presented at various conferences.
The Movement Disorders Program at Capital Institute for Neurosciences uses advanced therapies tailored to each patient’s diagnosis. Alongside drug treatments like levodopa, options may include deep brain stimulation as well as physical, speech, and occupational therapies to support comprehensive management of movement disorders.
